Pretreatment plasma fibrinogen level as a prognostic biomarker for patients with lung cancer. Clinics [Internet]. 2020 Feb. 28 [cited 2024 May 3];75:e993. Available from: https://www.revistas.usp.br/clinics/article/view/167124